Pfizer Takes On Mylan In Fight To Protect Lipitor
Pfizer Inc. has filed an infringement lawsuit against Mylan Inc., accusing the generic-drug maker of trying to market and sell generic versions of the blockbuster anti-cholesterol drug Lipitor before the expiration...To view the full article, register now.
Already a subscriber? Click here to view full article